Karus Therapeutics presenting at AACR Annual Meeting 2016

Oxford, UK, 29 March 2016– Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced it will be giving a poster presentation at the AACR Annual Meeting in New Orleans, 16-20 April 2016.

Stephen Shuttleworth, Karus’s CSO, will present the poster “KA2237 and KA2507: Novel, oral cancer immunotherapeutics targeting PI3K-p110β/p110δ and HDAC6 with single-agent and combination activity.”  The presentation will take place from 13:00 to 17:00 on Tuesday, 19 April 2016 in Section 26.

Simon Kerry, Karus Therapeutics’ CEO will also be attending the conference.

For more information on Karus’s presentations or for media enquiries, please contact karus@instinctif.com.